Last reviewed · How we verify
Placebo + aerobic exercise
Placebo combined with aerobic exercise improves cardiovascular and metabolic health through physical conditioning and the placebo effect.
Placebo combined with aerobic exercise improves cardiovascular and metabolic health through physical conditioning and the placebo effect. Used for Cardiovascular disease prevention and management, Metabolic syndrome and obesity.
At a glance
| Generic name | Placebo + aerobic exercise |
|---|---|
| Sponsor | University of Göttingen |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular, Metabolic |
| Phase | FDA-approved |
Mechanism of action
Aerobic exercise enhances cardiovascular function, increases oxygen utilization, and improves metabolic parameters through physiological adaptation. The placebo component may augment these benefits through psychological mechanisms including expectation effects and improved adherence. Together, this combination leverages both physiological exercise benefits and psychosomatic enhancement.
Approved indications
- Cardiovascular disease prevention and management
- Metabolic syndrome and obesity
Common side effects
- Musculoskeletal strain or injury
- Fatigue
- Placebo-related expectation effects
Key clinical trials
- Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance (NA)
- Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. (PHASE2, PHASE3)
- The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity (PHASE4)
- NR and Exercise for Blood Pressure (NA)
- Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects (PHASE2, PHASE3)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- NAD+ and Exercise in FA (NA)
- ACUTE EFFECTS OF INSPIRATORY MUSCLE WARM-UP ON INSPIRATORY MUSCLE STRENGTH DURING AEROBIC AND ANAEROBIC EXERCISE IN ATHLETES (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo + aerobic exercise CI brief — competitive landscape report
- Placebo + aerobic exercise updates RSS · CI watch RSS
- University of Göttingen portfolio CI